Truist Securities Maintains Buy on Progyny, Lowers Price Target to $26
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Buy rating on Progyny (NASDAQ:PGNY) but lowered the price target from $33 to $26.
September 19, 2024 | 4:32 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Truist Securities has maintained a Buy rating on Progyny but reduced the price target from $33 to $26, indicating a more cautious outlook.
The maintenance of a Buy rating suggests continued confidence in Progyny's potential, but the lowered price target reflects a more cautious outlook on its short-term performance. This mixed signal may result in neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100